Clik here to view.
PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use...
GOLDEN, Colo. Following assessment of the primary endpoints of the Phase II/III study, PharmaJet partner Gennova Biopharmaceuticals Limited has submitted data for its mRNA-based Omicron specific...
View ArticleClik here to view.
athenahealth and Smile Foundation Launch Second Mobile Medical Unit in Bengaluru
WATERTOWN, Mass. athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, and Smile Foundation today announced the expansion...
View ArticleClik here to view.
2023年Aster Guardians Global Nursing Award十强护士名单出炉，他们将角逐25万美元大奖
阿拉伯联合酋长国迪拜 (美国商业资讯) — Aster Guardians Global Nursing Award这一奖项是为了表彰世界各地的护士做出的突出贡献，目前公布了从世界各地遴选出的十强护士。他们分别是：来自阿拉伯联合酋长国的Cathy Cribben-Pearse、来自肯尼亚的Christine Mawia Sammy、来自巴拿马的Gloria...
View ArticleClik here to view.
アスター・ガーディアンズ・グローバル・ナーシング・アワード2023（US$250,000相当）のファイナリスト上位10名の看護師を発表
ドバイ、アラブ首長国連邦 （ビジネスワイヤ） — 世界中の看護師による感動的な活動を表彰する「アスター・ガーディアンズ・グローバル・ナーシング・アワード」は、世界各国から集まったファイナリスト10名を発表しました。受賞者は以下の通りです：...
View ArticleClik here to view.
OrganaBio Delivers RUO ＆ GMP LeukoPAC™ Collections to Singapore
MIAMI The monoclonal antibodies (mAbs) daratumumab, and elotuzumab have been approved by the U.S. Food and Drug Administration for treating multiple myeloma (MM) in 2015. Although clinical responses...
View ArticleClik here to view.
Myomo Receives Technology License Fee Payment from China Joint Venture Company
BOSTON Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and...
View ArticleClik here to view.
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia...
NEW YORK Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction,...
View ArticleClik here to view.
Bone Biologics Receives Human Research Ethics Committee Approval to Begin...
BURLINGTON, Mass. Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that the Human Research Ethics Committee (HREC) has approved...
View ArticleClik here to view.
Mary Kay and International Telecommunication Union Announce Winners of the...
DALLAS Taking place on the margins of the Commission on the Status of Women (CSW67), the International Telecommunication Union (ITU), with support from Mary Kay Global, announced the ten winning...
View ArticleClik here to view.
Bio-Thera Solutions Announces BAT1006 Poster Presentations at the 2023 AACR...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced the company will present one poster concerning Phase 1 clinical results for...
View ArticleClik here to view.
メアリー・ケイと国際電気通信連合、「女性起業家アクセラレーター デジタル・イノベーション・チャレンジ」の受賞者を発表
ダラス （ビジネスワイヤ） — 国連女性の地位委員会（CSW67）の傍ら、...
View ArticleClik here to view.
玫琳凯和国际电信联盟公布女性创业加速器数字创新挑战赛的获胜者名单
达拉斯 (美国商业资讯)– 在联合国妇女地位委员会第六十七届会议（CSW67）期间，国际电信联盟（ITU）在玫琳凯全球（Mary Kay Global）的支持下，在纽约市大都会人寿保险公司总部举办了一场盛大活动，并在现场公布了女性创业加速器（WEA）数字创新挑战赛的十家获胜企业。出席此次活动的有来自联合国、私营部门、投资者和民间社会组织的代表。另外，三家初创公司Tiny Totos、Gwiji...
View ArticleClik here to view.
KBIバイオファーマとセレクシスがJ.D.マワリーを最高経営責任者（CEO）に任命
DURHAM, N.C. （ビジネスワイヤ） — JSRライフサイエンス傘下にあるKBIバイオファーマとセレクシスの両社は、本日、J.D.マワリーを最高経営責任者（CEO）に任命したことを発表しました。...
View ArticleClik here to view.
KBI Biopharma和Selexis任命J.D. Mowery为首席执行官
北卡罗来纳州达勒姆 (美国商业资讯)–JSR Life Sciences旗下公司KBI Biopharma, Inc. (KBI) 和Selexis SA今天宣布任命J.D. Mowery为首席执行官。J.D.作为创新生物技术领导者一直广受尊崇，在激励同事和团队建设方面拥有近25年的成功经验，他将带领KBI和Selexis成为新兴的下一代CDMO领导者。...
View ArticleClik here to view.
Armis宣布在医疗保健领域取得强劲的业务发展势头
芝加哥 (美国商业资讯)–医疗卫生信息与管理系统协会 ——领先的资产可见性和安全公司Armis今日宣布，由于医疗保健和生命科学公司纷纷选择Armis...
View ArticleClik here to view.
Clik here to view.
BeiGene Announces Positive Phase 3 Tislelizumab Trial in Advanced Gastric or...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the global RATIONALE 305 trial met its...
View ArticleClik here to view.
Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented...
FORT LEE, N.J. Luxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI), Rensselaer, New York, today announced the...
View ArticleClik here to view.
PharmaEssentia Corporation Announces Closing of Global Depositary Receipt...
TAIPEI, Taiwan PharmaEssentia Corporation (TPEx:6446, LuxSE: PHECA, PHECR), a leading fully integrated biopharmaceutical company in Taiwan, today announced the closing of its Global Depositary...
View ArticleClik here to view.
Albatroz Therapeutics Secures $3 Million to Develop First-Ever Therapy...
SINGAPORE Albatroz Therapeutics, a biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, today announced it has secured $3 million USD in funding led by Outram...
View Article